ABOUT US

We are a hands-on investor taking leading positions and understanding the balance between finance, commercial assets and people.

With a long track record in life science dating back to 1995, Aravis partners have been lead investors in some of the first wave Swiss life sciences companies such as Glycart, Evolva, Symetis, Esbatech and Novimmune. We have also invested …
With a long track record in life science dating back to 1995, Aravis partners have been lead investors in some of the first wave Swiss life sciences companies such as Glycart, Evolva, Symetis, Esbatech and Novimmune. We have also invested with great success in renewable energy projects and in luxury companies at an international level. In all our transactions, we strive to lead and structure the financing rounds, taking active and senior board positions.
Today, our team comes from different backgrounds like private equity, corporate finance, serial entrepreneurship or C-level management of large companies. This allows us to support our portfolio companies in the growth phase with our human, industrial, financial and capital markets global networks.
+

TIMELINE

2017
Growth I
Aravis Growth is a new initiative. With a strong focus on growth funding in Switzerland we will build a portfolio in the sectors of Biotech, Creative and Digital as well as Industrial High Tech. Actively accelerating the best companies to…

Aravis Growth is a new initiative. With a strong focus on growth funding in Switzerland we will build a portfolio in the sectors of Biotech, Creative and Digital as well as Industrial High Tech. Actively accelerating the best companies to international success and making use of years of experience, our team will fill an important gap in the Swiss market.
Team: Jean-Philippe Tripet, Stephan Schnürer, TBA

Aravis Growth

+
2011
Energy II
The Aravis Energy funds have been taking controlling positions in a series of privately-held companies that own and operate renewable energy production infrastructure. Aravis has been at the forefront of developments in the energy market and has established itself as…

The Aravis Energy funds have been taking controlling positions in a series of privately-held companies that own and operate renewable energy production infrastructure. Aravis has been at the forefront of developments in the energy market and has established itself as a European investment leader with an excellent track record and financial performance. Aravis Energy II (Leading Swiss Renewable AG) was successfully sold and thus does not make new investments.

Energy II

+
2010
Luxury
The team works on a deal by deal basis with a strategy of linking Italian and French luxury goods to Asian emerging luxury brands. The Aravis luxury goods team plays an active role to finance, develop and exit its companies.…

The team works on a deal by deal basis with a strategy of linking Italian and French luxury goods to Asian emerging luxury brands. The Aravis luxury goods team plays an active role to finance, develop and exit its companies.
Team: Jean-Philippe Tripet, Gerald Mazzalovo

Luxury

+
2009
Energy I
The Aravis Energy funds have been taking controlling positions in a series of privately-held companies that own and operate renewable energy production infrastructure. Aravis has been at the forefront of developments in the energy market and has established itself as…

The Aravis Energy funds have been taking controlling positions in a series of privately-held companies that own and operate renewable energy production infrastructure. Aravis has been at the forefront of developments in the energy market and has established itself as a European investment leader with an excellent track record and financial performance. Aravis Energy I was successfully liquidated and thus does not make new investments.

Energy I

+
2007
Biotech II
Biotech II follows its predecessor’s strategy and focuses on European, Asian and North American early stage biopharmaceutical, medical technology and biotechnology companies. The fund is in realization phase and does not make new investments. Team: Jean-Philippe Tripet, Simon Nebel Biotech…

Biotech II follows its predecessor’s strategy and focuses on European, Asian and North American early stage biopharmaceutical, medical technology and biotechnology companies. The fund is in realization phase and does not make new investments.
Team: Jean-Philippe Tripet, Simon Nebel

Biotech II

+
2003
Biotech I
Biotech I is the first fund launched by Aravis and 5AM Ventures, with a focus on European, Asian and North American early stage biopharmaceutical, medical technology and biotechnology companies. The fund is in realization phase and does not make new…

Biotech I is the first fund launched by Aravis and 5AM Ventures, with a focus on European, Asian and North American early stage biopharmaceutical, medical technology and biotechnology companies. The fund is in realization phase and does not make new investments.
Team: Jean-Philippe Tripet, John Diekman, Andy Schwab, Simon Nebel

Biotech I

+
2001
Aravis SA founded

Aravis SA was founded in 2001 by Jean-Philippe Tripet after a successful international career at UBS and Lombard Odier.

PEOPLE

Aravis is managed and advised by an international team of industrial and venture capital experts.
Jean-Philippe Tripet

Jean-Philippe Tripet

lic.oec, CFA

Founder and Chairman

Venture / Growth
+

During his career, Jean-Philippe has led and supervised over 100 investments in private companies worldwide.He has been active in Private Equity since 1994.

He is a member of the Steering Committee of the Swiss Entrepreneurs Foundation. He is also a member of the Advisory committee on Digital Transformation for the Swiss Government.

Prior to founding Aravis, he was a Senior Executive Vice-President and member of the Group Executive Committee at Lombard Odier & Cie, Geneva. Before that, he was vice-President, Equity Research at UBS in Zurich and London.

He has a degree in business administration from the University of Geneva, did graduate studies in finance in San Diego, California and is a Chartered Financial Analyst since 1993. He lectures at the University of Lugano.(USI)

Stephan Schnürer

Stephan Schnürer

lic.oec,HSG

Managing Partner

Private Equity
+

Stephan Schnürer is also founder and Managing Partner of PartnerVest AG, an investment advisory company.

Prior to founding PartnerVest, he chaired the investment committee which was responsible for the global Private equity fund investment activities within UBS Asset Management. He was also a voting member of the Infrastructure & Real Asset Investment committee within UBS Asset Management.

He oversaw a global private equity portfolio of more than 200 holdings during his career at UBS and invested in a number of secondary, fund and co-investments through PartnerVest on behalf of family office clients.

He holds a Masters degree in business administration from the University of St. Gallen.

Managing Partner 1 – To be announced

Managing Partner 1 – To be announced

MBA, CFA

Managing Partner

Corporate Finance
+
Managing Partner 2 – To be announced

Managing Partner 2 – To be announced

MBA, MS

Managing Partner

Information Technology/Digital
+
Claudia Zimmermann

Claudia Zimmermann

Economist SEBA, CFA

Venture Partner

CFO Industry
+

Claudia Zimmermann is also the founder and CEO of C-Advisory GmbH, an advisory firm to support sustainable growth for companies. She is on the BoD of ADEV Energiegenossenschaft, Vice President of the Board of ADEV Wasserkraftwerke AG and a Juror of Venture.ch.

Before founding C-Advisory, she was the CFO of the Noser Group, an internationally operating Swiss-based ICT-Group. She gathered profound experience as a consultant with PwC Valuation & Strategy in Infrastructure, Utilities & Transportation and the Public Sector (e.g. PPPs). Claudia started her career with industrial companies (Rieter, ABB) and worked or studied in various countries around the globe.

She holds a degree as Economist SEBA, is a CFA-Charterholder and holds a CAS Applied History of the University of Zurich. She attended Executive Programs at Harvard Business School, IMD and various expert seminars.

 

Ursula Rüegsegger

Ursula Rüegsegger

PhD

Venture Partner

CEO Industry
+

Ursula Rüegsegger is the CEO of Sanacare AG, an ambulatory care provider with doctor’s offices at 13 different sites across Switzerland.

 

Prior to leading Sanacare she was General Manager Switzerland of Baxter. She has over 15 years of international and national strategic consulting and execution experience in Life Sciences resulting from leadership positions in large and mid-sized companies as well as 7 years at McKinsey & Company. Leveraging her experience, she advises investors and mentors entrepreneurs of start-up and SME companies with a focus on the healthcare and life science sector.

 

Ursula is a biochemist with a PhD and a postdoctoral degree from the University of Basel and the University of California at San Francisco, respectively.

 

 

Andreas Jacobs

Andreas Jacobs

PhD

Venture Partner

Regulatory & Finances
+

Andreas Jacobs is currently the CEO of SFAA (Swiss Financial Analysts Association) & AZEK-Swiss Training Centre for Investment Professionals.

Prior to this, he spent 7 years as CFO of the Aravis Group. Before joining Aravis, he was formerly a Managing Director of UBS’s asset and wealth management business groups. He specialized in product management and held senior positions in London, Zürich, Basel and Bern. He was CEO of UBS Alternative Portfolio AG and Chairman of the Board of UBS Fund Management (Switzerland) AG as well.

Furthermore he also lectures on finance at the University of Bern, the Institute for Applied Science (ZHAW) in Winterthur and the PHW Business School Berne. In addition he is Chairman of the Board of OLZ & Partners Asset and Liability Management AG in Bern.

Andreas holds a doctorate in Business Administration from the University of Bern.

Simon Nebel

Simon Nebel

PhD, MBA

Managing Partner

Biotech
+

Simon Nebel has participated in the financing in a number of life science companies and the M&A transactions for Aravis portfolio companies. He was a co-founder of Aravis Energy I LP, the first Swiss Limited Partnership focused on renewable energy. Simon has been board member or observer in fourteen companies and is currently board member of SynAffix (NL), MarinoMed (AT), Bird Rock Bio (La Jolla/USA)) and BioSilu Healthcare (DE).

Before joining Aravis, he was a group strategist at UBS (London, Basel and Zurich), where he coordinated and worked on business planning and modelling, including developing a Biotechnology Venture Capital proposal for UBS Capital.

He holds a PhD in Biophysics from the Biocentre of the University of Basel (1996) and an MBA with distinction from the London Business School (2001).

Gerald Mazzalovo

Gerald Mazzalovo

MBA, EDBA

Venture Partner

Luxury
+

Gerald Mazzalovo is currently the Group CEO of  Jim Thompson in Thailand.

He held positions as President and CEO at luxury companies such as Salvatore Ferragamo, Loewe, Robert Clergerie and Bally. He was a consultant at Arthur Andersen and advised many multinational firms on strategic brand management. He is also a Visiting Professor at IE Business School in Madrid and Université Paris-Dauphine.

Gerald holds a chemical engineering degree from ENSCS (Strasbourg), an MBA from Columbia University and an Executive Doctorate in Business Administration from Université Paris-Dauphine. He is the author of several books and articles on Brand Management.

Martin Eisenring

Martin Eisenring

Dr. iur.

Legal and Compliance Consultant

Legal and Compliance
+

Martin Eisenring works as an independent Attorney-at-law & Notary Public in Zug.

Before founding his own law firm he was a managing partner of the Zug office of one of the leading Swiss business law firms. He also gathered experience in the area of shareholder activism with a Geneva based investment foundation. He has many years of consultancy experience in the broad areas of business law, with his main focus being in the fields of corporate law, commodity trading, private equity and pension funds.

He studied law at the University of Fribourg and received his PhD (Dr. iur.) from the University of Zurich. Furthermore, he holds an executive diploma from the University of St. Gallen and the Certificate of Advance Studies (CAS) from the University of Lucerne

Jean Eric Hiltbrunner

Jean Eric Hiltbrunner

Chief Financial Officer

Biotech
+

Jean Eric Hiltbrunner is the Chief Financial Officer of Aravis Biotech II.

He formerly held positions as the General Manager of many large Swiss pension funds (Bühler AG, Hewlett-Packard Schweiz GmbH, Compaq Computer (Schweiz) GmbH and NCR (Schweiz)). Between 2001 and 2017 he was a member of the Board of Trustees of Assetimmo Immobilien-Anlagestiftung.

Prior to that, he was employed as the CEO / CFO of several US and Japanese companies in Switzerland.

Dersim Avdar

Dersim Avdar

Investment Manager

+

Prior to joining Aravis, he gathered experience at UBS Investment Bank in Zürich and Banque Pictet in Geneva. He also did a consulting project for a Chinese venture fund in Beijing in parallel to a study semester spent there. He is a Venture Kick jury member.

He studied Banking and Finance at the University of St. Gallen, with semesters spent abroad at Universidad Carlos III in Madrid and at Tsinghua University in Beijing. He also cofounded the Tech Club at the University of St. Gallen, to bridge the gap between students and innovative companies, and raise awareness about the potential of disruptive technologies. He is a CFA candidate and a passionate gamer.

Evangeline de Macedo

Evangeline de Macedo

PA to Chairman

Administration
+

Evangeline de Macedo undertakes all the administration and personnel duties of Aravis and is the PA to Jean-Philippe Tripet.

Prior to this she first worked for the Export Service Zentrum in Arnhem, Netherlands as a market research analyst before joining Singapore Airlines, where she oversaw the functions of accounting departments in Singapore, Germany and Switzerland. She was also employed by the Singapore Tourism Board in Zurich as well as the British Swiss Chamber of Commerce to perform administration and accounting functions.

Evangeline holds an Honors degree in Business Administration from the National University of Singapore.

Margaretha Bruelisauer

Margaretha Bruelisauer

Accountant

Accounting
+

Margaretha Bruelisauer is responsible for the accounting functions.

Prior to joining Aravis, she worked for several auditing and accounting companies in Zürich.

She has a Federal Certificate in accounting.

Léna Tripet

Léna Tripet

Analyst

+

Léna Tripet was a Risk and Insurance Management trainee at Gategroup and Symetis SA, where she did data analysis and developed key performance indicators.

She studies towards a Masters degree in International Finance Management at the Hochschule Luzern and holds a Bachelors degree from ZHAW, School of Management and Law. She did a one year student exchange study at Montreal University in Quebec.

PORTFOLIO

Since the creation of aravis we have been actively partnering with all our companies. We look for entrepreneurs with a vision, teams who want to transform life and business. Our aravis partners will invest time, talent and experise. We will provide strategic advice, domain expertise and capital to help realise and accelerate growth.
Status: All Current Exited
Sector: All Growth Biotech Energy Luxury
img

ADMINISTRATION PLATFORM

Aravis is the first independent firm to have filed a Swiss onshore Limited partnership with FINMA. The administration team has built a reliable accounting, investment valuation, compliance, reporting and administrative experience. Since 2008, we have successfully received approval for 4 different partnerships. This collective expertise forms a platform that Aravis offers to external partners. If you are interested in hearing more about how Aravis could help, please contact us at info@aravis.ch.

CONTACT

ARAVIS SA
Merkurstrasse 70
CH-8032 Zurich
Switzerland

Tel. +41 43 499 2000
Fax +41 43 499 2001
info@aravis.ch